All Pharma News
price-trendAsk Us
Saol Therapeutics Announces Completion of Enrollment in Both the PII Trial

Saol Therapeutics Announces Completion of Enrollment in Both the PII Trial
PR NEWSWIRE
19 Sep 2023
Share Share
Saol Announces Enrollment in Pivotal PIII Trial for Rare Mitochondrial Disease

Saol Announces Enrollment in Pivotal PIII Trial for Rare Mitochondrial Disease
PRNEWSWIRE
04 Oct 2022
Share Share
Saol enrols first subject in Phase II osteoarthritis trial

Saol enrols first subject in Phase II osteoarthritis trial
CLINICAL TRIALS ARENA
10 Aug 2022
Share Share
Saol Therapeutics Begins Enrollment in PII COMPASS Trial of SL-1002

Saol Therapeutics Begins Enrollment in PII COMPASS Trial of SL-1002
PRNEWSWIRE
09 Aug 2022
Share Share
Amneal Acquires Saol Therapeutics’ Baclofen Franchise

Amneal Acquires Saol Therapeutics’ Baclofen Franchise
BUSINESSWIRE
05 Jan 2022
Share Share